Browsing by Author "Sakai, Hiroshi"
Now showing items 1-3 of 3
-
Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management
Veillon, Remi; Sakai, Hiroshi; Felip Font, Enriqueta; Cortot, Alexis; Smit, Egbert; Le, Xiuning (Elsevier, 2022-06) -
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice
Sakai, Hiroshi; Felip Font, Enriqueta; Veillon, Remi; Garassino, Marina Chiara; Raskin, Jo; Le, Xiuning (American Association for Cancer Research, 2022-03-15) -
Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial
Paik, Paul K.; Garassino, Marina; Le, Xiuning; Sakai, Hiroshi; Veillon, Remi; MAZIERES, JULIEN; FELIP, ENRIQUETA (American Medical Association, 2023-09-01)